GGrantIndex
Sort

64,565 grants matching drug discovery

Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection

$632,904
Elliot J Androphy · Indiana University Indianapolis · R01 · FY2021 · CA

WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE

$632,875
Kooresh Isaac Shoghi · Washington University · U24 · FY2017 · CA

STRUCTURE, MECHANISM AND INHIBITION OF HIV PROTEINS

$632,844
Harvard University · P01 · FY2000 · GM

NF2-associated meningiomas: From omics discovery to targeted therapy

$632,818
Vijaya Ramesh · Massachusetts General Hospital · R01 · FY2022 · NS

NF2-associated meningiomas: From omics discovery to targeted therapy

$632,818
Vijaya Ramesh · Massachusetts General Hospital · R01 · FY2021 · NS

NF2-Associated Meningiomas: From Omics Discovery to Targeted Therapy

$632,818
Vijaya Ramesh · Massachusetts General Hospital · R01 · FY2023 · NS

A novel high-content high-throughput screening platform

$632,787
Cyntellect, Inc. · R44 · FY2004 · RR

Temperature-Controlled Recording System for Wireless Data Acquisition from Immature Rodents

$632,775
Manoel Rowe · Biopac Systems, Inc. · R44 · FY2024 · MH

TELOMERASE: A MOLECULAR TARGET FOR CANCER THERAPY

$632,753
Geron Corporation · U19 · FY2001 · CA

Plasmodium Genome Database

$632,753
University Of Pennsylvania · R01 · FY2005 · AI

Genetic modifiers of atherosclerosis and macrophage phenotypes

$632,638
Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · HL

Genetic modifiers of atherosclerosis and macrophage phenotypes

$632,638
Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · HL

Lethal Mutagenesis as an Antiviral Strategy

$632,606
Pennsylvania State University-Univ Park · U01 · FY2003 · AI

Nano-scale proteomic analysis: development, implementation, and applications

$632,556
Jinqiu Chen · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

Preclinical Development of a Therapeutic Agent for COPD

$632,540
Biomarck Pharmaceuticals, Ltd · R44 · FY2004 · HL

HBV Capsid Effectors

$632,520
Raymond F. Schinazi · Emory University · R01 · FY2024 · AI

Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases

$632,476
Michael Berney · Albert Einstein College Of Medicine · R01 · FY2020 · AI

MCSP TORFP NO. NIH-NINDS-21-01: FLORIO (ANAGIN) - BASE EC (STROKE)

$632,321
Melissa Allard · Albany Molecular Research, Inc. · N01 · FY2021 · DA

CAREER: Multimodal Nanoelectrochemistry to Characterize Nanometer and Microsecond Resolved Transmitter Release

$632,319
Mei Shen · University Of Illinois At Urbana-Champaign · · FY2019 · MPS

INTEGRATED PLACENTAL IMAGING: NOVEL METHODS FOR PROBING FUNCTION AND METABOLISM

$632,286
Joel Richard Garbow · Washington University · R01 · FY2019 · HD

Knee OA: Setting Priorities for Care, Policy, Research

$632,252
Elena Losina · Brigham And Women'S Hospital · R01 · FY2010 · AR

Mechanistic Characterization of Uterine Pain (M-CUP) to improve diagnosis and treatment for dysmenorrhea

$632,252
Kevin Hellman · Endeavor Health Clinical Operations · R01 · FY2019 · HD

Genetic Analysis of Protein Export

$632,230
Thomas J. Silhavy · Princeton University · R01 · FY2012 · GM

Stereoselective Atom Transfer

$632,228
Scripps Research Institute · R01 · FY2005 · GM

Heartland Institute for Clinical and Translational Research

$632,191
Richard J. Barohn · University Of Kansas Medical Center · KL2 · FY2015 · TR